Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands.

van der Kooij, M K; Joosse, A; Speetjens, F M; Hospers, G A P; Bisschop, C; de Groot, J W B; Koornstra, R; Blank, C U; Kapiteijn, E

van der Kooij, M K; Joosse, A; Speetjens, F M; Hospers, G A P; Bisschop, C; de Groot, J W B; Koornstra, R; Blank, C U; Kapiteijn, E.

Affiliation

van der Kooij MK; a Department of Clinical Oncology , Leiden University Medical Center , Leiden , The Netherlands.
Joosse A; a Department of Clinical Oncology , Leiden University Medical Center , Leiden , The Netherlands.
Speetjens FM; a Department of Clinical Oncology , Leiden University Medical Center , Leiden , The Netherlands.
Hospers GA; b Department of Medical Oncology , University Medical Center Groningen , Groningen , The Netherlands.
Bisschop C; b Department of Medical Oncology , University Medical Center Groningen , Groningen , The Netherlands.
de Groot JW; c Department of Medical Oncology , Isala , Zwolle , The Netherlands.
Koornstra R; d Department of Medical Oncology , Radboud University Medical Center , Nijmegen , The Netherlands.
Blank CU; e Department of Medical Oncology , Netherlands Cancer Institute (NKI-AVL) , Amsterdam , The Netherlands.
Kapiteijn E; a Department of Clinical Oncology , Leiden University Medical Center , Leiden , The Netherlands.

Acta Oncol ; 56(1): 101-103, 2017 Jan.

Article in En | MEDLINE | ID: mdl-27911126

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Antibodies, Monoclonal/therapeutic use; Antineoplastic Agents/therapeutic use; Melanoma/drug therapy; Programmed Cell Death 1 Receptor/immunology; Uveal Neoplasms/drug therapy; Adult; Aged; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Melanoma/epidemiology; Melanoma/secondary; Middle Aged; Neoplasm Staging; Netherlands/epidemiology; Nivolumab; Prognosis; Programmed Cell Death 1 Receptor/antagonists & inhibitors; Survival Rate; Uveal Neoplasms/epidemiology; Uveal Neoplasms/secondary

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uveal Neoplasms / Antibodies, Monoclonal, Humanized / Programmed Cell Death 1 Receptor / Melanoma / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2017 Type: Article Affiliation country: Netherlands

Fulltext

XML

PubMed Links

Search on Google